Is MoneyHero Ltd. overvalued or undervalued?
As of February 9, 2023, MoneyHero Ltd. is considered overvalued and risky due to its negative P/E and EV/EBITDA ratios, lack of growth prospects, and underperformance compared to industry peers, despite a strong year-to-date return that is overshadowed by significant long-term volatility.
As of 9 February 2023, the valuation grade for MoneyHero Ltd. has moved from fair to risky, indicating a potential concern regarding its valuation. The company appears to be overvalued, as evidenced by its P/E ratio of -2.55 and EV/EBITDA ratio of -1.42, which are significantly below industry standards. Additionally, the absence of a PEG ratio suggests a lack of growth prospects, further reinforcing the overvaluation stance.In comparison to peers, MoneyHero Ltd. is underperforming, with its P/E ratio and EV/EBITDA metrics indicating a less favorable position than competitors in the software and consulting industry. Notably, while MoneyHero has shown impressive returns of 98.21% YTD compared to the S&P 500's 12.22%, this performance is overshadowed by a drastic decline of -77.82% over the past three years, highlighting volatility and potential risk.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
